3
Announcements
Trials
Browse
Landscape
Phase
Phase 2
1
Status
Not yet recruiting
1
Sponsor Class
INDUSTRY
1
Study Type
Interventional
1
Sponsor
Cancer Type
Dermatologic
1
Conditions
Lymphoma, T-Cell, Cutaneous
30
Precursor Cell Lymphoblastic Leukemia-Lymphoma
28
Lymphoma, Follicular
28
Lymphoma, B-Cell, Marginal Zone
28
Leukemia, Lymphocytic, Chronic, B-Cell
28
Lymphoma, Non-Hodgkin
27
Lymphoma, Mantle-Cell
26
Lymphoma, Large B-Cell, Diffuse
26
Sezary Syndrome
25
Mycosis Fungoides
25
Leukemia, Myeloid, Acute
25
Hodgkin Disease
25
Multiple Myeloma
24
Lymphoma, Large-Cell, Immunoblastic
24
Congenital Abnormalities
24
Burkitt Lymphoma
24
Leukemia, Myeloid, Chronic-Phase
20
Leukemia, Myeloid, Accelerated Phase
20
Precursor T-Cell Lymphoblastic Leukemia-Lymphoma
19
Lymphoma, Extranodal NK-T-Cell
19
Myeloproliferative Disorders
18
Lymphoma, Large-Cell, Anaplastic
18
Waldenstrom Macroglobulinemia
17
Recurrence
16
Leukemia, Myelomonocytic, Chronic
16
Immunoblastic Lymphadenopathy
16
Dendritic Cell Sarcoma, Interdigitating
16
Lymphoma
15
Leukemia, Hairy Cell
15
Leukemia
15
Interventions
Infliximab
3
vedolizumab
2
Fecal Microbiota Transplantation
2
Prednisone
1
Photopheresis
1
Mycophenolic Acid
1
Methylprednisolone Hemisuccinate
1
Methylprednisolone
1
Methoxsalen
1
Loperamide
1
LDP-02
1
Immunoglobulin G
1
Disulfides
1
CT-P13
1
Azathioprine
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
Colitis
×
Mycophenolic Acid
×
Dermatologic
×
Clear all
NCT07619898
2026-06-02
PHOENIX-ECP
Therakos LLC
Phase 2
Not yet recruiting
112 enrolled